medigraphic.com
ISSN 1561-3046 (Electronic)

2016, Number 3

<< Back Next >>

Rev Cub Med Mil 2016; 45 (3)

Cognitive Impairment and Quality of Life of the Elderly with Renal Replacement Therapy

Capote LE, Casamayor LZ, Castañer MJ, Rodríguez AN, Moret HY, Peña RR

Language: Spanish
References: 28
Page: 354-364
PDF size: 121.20 Kb.


ABSTRACT

Introduction: Cognitive impairment is strongly associated with cardiovascular risk factors. Chronic kidney disease, especially those that have progressed to stage 5 and require renal replacement therapy such as hemodialysis, are now considered a cardiovascular risk factor.
Objective: Determine the prevalence of cognitive impairment in older adults with chronic renal failure and renal replacement therapy and its relationship with quality of life.
Methods: An observational, analytical and cross-sectional study was carried out involving 30 patients with ? 60 years of age from the nephrology department of Dr. Carlos J. Finlay Clinical Surgical Teaching Hospital These subjects had treatment of hemodialysis and peritoneal dialysis. To establish cognitive impairment, the minimental test was used with a value of less than 23 points; the quality of life was assessed using the Karnofsky index. Pearson's chi-square test was used to determine the relationship between qualitative variables and the relative risk (RR) test was used to determine the degree of association between the associated variables.
Results: Cognitive impairment was found in 16.6% of the patients; 80% were related to poor quality of life (X2 = 4.0, p = 0.046, RR = 2.5 ICI = 1.22, ICS = 5.14).
Conclusions: High prevalence of cognitive impairment was found in the group of patients studied and it was related to poor quality of life.


REFERENCES

  1. Lage A, Crombet T. Control of Advanced Cancer: The Road to Chronicity. Int. J. Environ. Res. Public Health. 2011;8:683-97.

  2. Roth B, Krilov L, Adams S, Aghajanian C, Bach P, Braiteh F, et al. Clinical Cancer Advances 2012: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J Clin Oncol. 2013;31(1):131-61.

  3. Más P. Addressing Cuba's aging population: Why epimapping needs to go local. MEDICC Review. 2011;13(1):56.

  4. National statistical bureau (CU). Proyecciones de la población cubana 2010-2030 [internet]. Havana. National statistical bureau (CU); 2006 [cited 2010 Dec 10]. Available from: http://www.one.cu/publicaciones/cepde/envejecimiento/envejecimiento2009.pdf

  5. Ministerio de Salud Pública. Dirección Nacional de Registros Médicos y Estadísticas de Salud 2013. Anuario Estadístico de salud 2012.

  6. Oficina Nacional de Estadística e Información. República de Cuba. Censo de Población y Viviendas 2012.

  7. Coyula M. Havana: Aging in an aging city. MEDICC Review. 2010;12(4):27-9.

  8. Buro Nacional de Estadísticas (CU). El envejecimiento de la población. Cubay sus territorios. Cuba 2009. Centro de desarrollo y población [internet]. Habana. Buro Nacional de Estadísticas (CU); 2009 [citada 10 Dic 2010]. Disponible en: http://www.one.cu/publicaciones/cepde/envejecimiento/envejecimiento2009.pdf

  9. Almaguer López M. Diagnóstico Epidemiológico y Tratamiento Precoz de la Enfermedad Renal Crónica y sus Factores de Riesgo. En: Arce S, eds. Trasplante Renal y Enfermedad Renal Crónica. Sistemas de Leyes Integradoras. La Habana: Editorial Ciencias Médicas; 2009. p.23-31.

  10. Capote E, Casamayor Z, Castañer J. Variables de laboratorio como indicadores de calidad de vida en el adulto mayor con tratamiento sustitutivo de la función renal. Rev Cubana Med Mil[|internet]. 2010 [citada 26 Ago 2016];39(3-4):[aprox. 13p]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0138- 65572010000300008&script=sci_arttext

  11. Dirks JH. Prevention of chronic kidney disease and vascular disease. Toward global health equity. The Bellagio 2004 Declaration. Kidney Int 2005;Suppl98:S1- S6.

  12. Saydah S. Prevalence of Chronic Kidney Diseaseand Association risk Factors. United States 1999-2004. MMWR. 2007;56(8):161-5.

  13. Almaguer M, Herrera R, Pérez Oliva J. Epidemia Global de Enfermedades Vasculares Crónicas. Un nuevo paradigma y desafío. Rev Hab de Ciencias Médicas. 2007;6(3):5.

  14. Herrera R. Enfermedad Renal Crónica: Problema biológico, psicológico y Social. En: Arce S, eds. Trasplante Renal y Enfermedad Renal Crónica. Sistemas de Leyes Integradoras. La Habana: Editorial Ciencias Médicas; 2009. p.23-31.

  15. Llibre Rodríguez, JJ. Usted puede prevenir la enfermedad de Alzheimer. La Habana: Editorial Científico Técnica; 2009.

  16. Blesa González R. Enfermedad de Alzheimer y otras demencias degenerativas. En: Rozman C, Cardellach F, editores. Medicina Interna. 17ma ed. Barcelona: Elsevier; 2012.p.1382-85.

  17. Fadili W, Al Adlouni A, Louhab N, HabibAllah M, Kissani N, Laouad I. Prevalence and risk factors of cognitivedys function in chronic hemodialysis patients. Aging Ment Health. 2014 ;18(2):207-11.

  18. López J, Martí G. Examen Cognoscitivo (MEC). Rev Esp Med Legal. 2011;37(3):122-27.

  19. Samper NoaJA, Llibre Rodriguez JJ, Sánchez Catasús C, Pérez Ramos CL, Morales Jiménez E, Sosa Perez S, et al. Miniexamen mental en sujetos con deterioro cognitivo leve. Rev Cubana Med Mil. 2012;41(2):125-32.

  20. Anwar W, Ezzat H, Mohab A. Comparative study of impact of hemodialysis and renal transplantation on cognitive functions in ESRD patients. Nefrología. 2015;35(6):567-71.

  21. Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol. 2013;24:353-63.

  22. Sánchez MA, Malagón MA, Alonso N. Incidencia de las demencias en hemodiálisis. Apoyo al cuidador principal. Enferm Nefrol. 2013;16(1):31-35.

  23. ChenHJ, Qi R, Kong X, Wen J, Liang X, Zhang Z, et al. Theimpact of hemodialysis on cognitivedys function in patients withend-stage renal disease: a resting-state functional MRI study. Metab Brain Dis. 2015;30(5):1247-56.

  24. Mitchell S. Advanced dementia. N Engl J Med. 2015;372:2533-40.

  25. LlibreJJ, Ferri CP, Acosta D, Guerra M, Prince M. Prevalence of dementia in Latin America, India and China: A population based cross sectional survey. Lancet. 2008;372:464-74.

  26. Mendoça da Matta S, Matos Moreira J, Melo e Kummer A, Guimarães Barbosa I, Lúcio Teixeira A, Simoes e Silva AC. Cognitive Alterations in Chronic Kidney Disease: Anupdate. J Bras Nefrol. 2014;36(2):241-5.

  27. Gil JM, García MJ, Foronda J, Borrego JF, Sánchez MC, Pérez del Barrio P, et al. Calidad de vida relacionada con la salud en pacientes ancianos en hemodiálisis. Nefrología. 2003;XXIII(6):528-37.

  28. Seidel UK, Gronewold J, Volsek M, Todica O, Kribben A, et al. Physical, cognitive and emotional factors contributing to quality of life, functional health and participation in community dwelling in chronickidny disease. PLoSOne. 2014;9(3):e91176. doi: 10.1371/journal.pone.0091176. eCollection 2014.




2020     |     www.medigraphic.com